4basebio PLC (ETR:88Q)
Germany flag Germany · Delayed Price · Currency is EUR
6.65
0.00 (0.00%)
At close: Feb 13, 2026

4basebio Ratios and Metrics

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Market Capitalization
100187979990-
Market Cap Growth
-44.55%94.08%-2.09%9.32%--
Enterprise Value
882031009477-
Last Close Price
6.6514.407.957.956.90-
PS Ratio
48.39166.07165.56326.32224.12-
PB Ratio
4.535.87-170.2712.286.48-
P/TBV Ratio
4.876.12-13.116.57-
EV/Sales Ratio
43.15179.76172.11310.92192.20-
Debt / Equity Ratio
0.810.58-21.250.470.150.11
Net Debt / Equity Ratio
-0.56-0.74-14.54-0.17-0.69-0.87
Net Debt / EBITDA Ratio
0.731.63-0.940.232.4123.28
Net Debt / FCF Ratio
0.731.71-1.010.212.229.84
Asset Turnover
0.070.030.040.020.020.05
Inventory Turnover
1.540.860.710.200.481.61
Quick Ratio
10.3811.081.973.706.8418.85
Current Ratio
11.3611.302.213.896.9919.08
Return on Equity (ROE)
-209.34%-95.28%-231.29%-54.74%-23.83%-10.60%
Return on Assets (ROA)
-39.27%-28.23%-43.23%-26.85%-13.56%-4.10%
Return on Capital Employed (ROCE)
-44.60%-30.90%-84.70%-55.70%-26.80%-3.70%
Earnings Yield
-16.74%-7.96%-9.15%-5.89%-4.27%-
FCF Yield
-16.96%-7.38%-8.41%-6.70%-4.78%-
Buyback Yield / Dilution
-15.91%-6.47%-0.01%--37.05%-4.24%
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.